Back
Celldex Therapeutics Stock Predictions
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager
Buy
58
CLDX
Celldex Therapeutics
Last Price:
41.15
Seasonality Move:
-0.32%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Celldex Therapeutics Stock Forecast
- Over the next 52 weeks, Celldex Therapeutics has on average historically risen by 33.4% based on the past 38 years of stock performance.
- Celldex Therapeutics has risen higher in 15 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 39.47%
-
Is Celldex Therapeutics Stock Undervalued?
The current Celldex Therapeutics [CLDX] share price is $41.85. The Score for CLDX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal. - CLDX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Celldex Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Celldex Therapeutics has on average historically risen by 33.4% based on the past 38 years of stock performance.
Celldex Therapeutics Stock Rating
Buy
58
Celldex Therapeutics (CLDX)
is a Buy
Is Celldex Therapeutics overpriced?
- Celldex Therapeutics has risen higher in 15 of those 38 years over the subsequent 52-week period, corresponding to a historical accuracy of 39.47%
Celldex Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
celldex.com
52-Week Data
52-Week High:
53.18
52-Week Low:
22.11
Prediction Charts
Market Cap:
2.77B
Price in USD:
41.85
Volume:
933.2K
Beta:
1.80
Technical Analysis
SMA50:
38.36
SMA100:
37.70
SMA200:
38.66
52-Wk Change:
55.52%
Stock Predictions
-
Is Celldex Therapeutics stock public?
Yes, Celldex Therapeutics is a publicly traded company. -
What is the Celldex Therapeutics stock quote today?
The Celldex Therapeutics stock price is 41.85 USD today. -
How to buy Celldex Therapeutics stock online?
You can buy Celldex Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Aug-30 | 40.22 | 41.33 | 41.80 | 40.01 |
| Sep-3 | 41.34 | 41.50 | 44.25 | 40.52 |
| Sep-4 | 41.21 | 44.54 | 45.08 | 40.98 |
| Sep-5 | 44.58 | 43.48 | 44.77 | 42.71 |
| Sep-6 | 43.80 | 43.76 | 44.13 | 42.78 |
| Sep-9 | 44.00 | 42.28 | 45.15 | 41.71 |
| Sep-10 | 42.55 | 42.04 | 43.16 | 41.74 |
| Sep-11 | 41.79 | 41.64 | 42.36 | 41.22 |
| Sep-12 | 41.68 | 41.77 | 42.33 | 41.36 |
| Sep-13 | 42.16 | 44.16 | 44.28 | 41.97 |
| Sep-16 | 44.24 | 42.86 | 44.53 | 42.75 |
| Sep-17 | 43.34 | 41.24 | 44.87 | 41.11 |
| Sep-18 | 41.50 | 41.85 | 43.19 | 41.50 |
| Sep-19 | 42.89 | 41.16 | 43.02 | 40.82 |
Celldex Therapeutics Earnings
Celldex Therapeutics Earnings Report: Per Share Celldex Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Celldex Therapeutics Forecast Revenue Growth
Celldex Therapeutics Stock Analysis: Historical quarterly revenues per share for Celldex Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.19 per share, and a decrease next year of $0.66 per share.
* Celldex Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.